MedTrace Logo

An Open Label Study to Evaluate the Efficacy of Airgent in Treating Damaged and Wrinkled Skin

NCT00811161 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-06-04

No results posted yet for this study

Summary

The primary objective of this study is to Evaluate the effectiveness of treatment of wrinkles or damaged skin with the Airgent device.

The secondary objective of this study are to:

* Evaluate subjects' satisfactory of the treatment.
* Demonstrate the safety of the Airgent treatment by evaluation of adverse events.

Conditions

  • Wrinkles or Damaged Skin Condition

Interventions

DEVICE

Airgent

HA needle free injection, 3-4 treatments, 3-4 weeks apart

Sponsors & Collaborators

  • PerfAction Ltd.

    lead INDUSTRY

Principal Investigators

  • Dean D. AD-EL D. AD-EL, MD · Rabin Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-02-28
Completion
2010-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00811161 on ClinicalTrials.gov